Matthew Halma (@MatthewHalma) profile picture

Biophysicist | #Postviral syndromes, #longCOVID, #PACVS | Open Source Medicine Foundation | https://teapawt.net/t.co/kWFDPz3ED2

Joined October 2022
Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)
Matthew Halma retweeted
わかったような帯グラフがありますけど、実際には何にもわかってない状態で、世界中で拡大接種を決行したんですな。 血中単球が持続的にスパイクタンパクを保持するのも後からわかったんだし。
Replying to @MatthewHalma
8/ Spike persistence. Patterson et al. (HV&I 2025) studied 50 PCVS patients with no evidence of prior infection. In a subset tested by flow cytometry (n=12), they reported S1 in CD16+ monocytes up to 245 days after vaccination, plus raised sCD40L, CCL5, IL-6 and IL-8. The same group had earlier reported S1 persistence after infection. Fig: Patterson 2025 Fig 4 (CC BY-NC 4.0)
1
4
99
Matthew Halma retweeted
DocuSign wants $8,100/yr from a 15-person team just to sign PDFs. So I built SignuDoc: open source, one-click deploy to your own @vercel account, $0 per seat. White-label branding, full audit trails, tamper-evident seals and your documents never leave your cloud.
989
1,778
458
29,210
4,104,621
Matthew Halma retweeted
Loughborough University researchers studied 45 people and found that 33% of Long COVID patients developed metabolic acidosis after repeated light exercise. Elevated lactate and disrupted blood pH may help explain exercise intolerance and PEM. physoc.onlinelibrary.wiley.c…
6
50
3
199
5,470
Matthew Halma retweeted
They do not look the same biologically. But generalizing with symptoms they do. It's the biology that matters. Thats how you target mechanisms with therapeutics.
Long COVID and post-vaccine syndrome (PACVS) look nearly identical: fatigue, brain fog, PEM, dysautonomia. There’s still no single routine test that cleanly separates them. What are the leading biomarker candidates? Classical autoantibodies, GPCR autoantibodies + IL-6, microclot proteomics, and persistent spike protein. What are the gaps and what can existing science tell us? #LongCOVID #PACVS #Biomarkers youtu.be/4z_tcdLm8zg
3
5
16
898
Matthew Halma retweeted
Chevauchement entre la #CovidLongue et le #PACVS (syndrome post-vaccination aiguë contre la COVID-19) présenté ici par Matthew Halma (biophysicien, Open Source Medicine Foundation) Les deux conditions partagent le même tableau clinique principal : fatigue, brouillard cérébral, malaise post-effort et dysautonomie. Aucun test clinique de routine ne permet de les distinguer. Le fil passe en revue la littérature sur les biomarqueurs pour voir ce qu’elle révèle réellement. 🔴 Points principaux - Chevauchement massif des diagnostics : dans un registre de 191 patients PACVS, la majorité répondait aux critères de plusieurs syndromes à la fois (ME/CFS, POTS, MCAS, neuropathie des petites fibres). Seulement une minorité n’en présentait aucun. - Auto-anticorps classiques (Purpura et al., 2026) : taux plus élevés d’anticardiolipine IgM et d’anti-U1-RNP dans le PACVS que dans la COVID longue, mais échantillons petits et absence de groupe témoin. - Auto-anticorps de récepteurs + IL-6 (Semmler et al., 2023) : différences notables sur les anticorps AT1R, α2B-adrénergiques et l’IL-6 (AUC ~0,82-0,85), mais comparaison uniquement avec des vaccinés en bonne santé (pas avec la COVID longue) et absence de prélèvements pré-vaccination. - Micro-caillots : présence de micro-caillots fibrinoïdes documentée dans les deux conditions. La protéomique montre un chevauchement partiel des protéines piégées, mais les études restent limitées en taille d’échantillon et en standardisation. - Persistance de la protéine Spike : signalée dans les monocytes de patients PACVS sans infection antérieure documentée (Patterson et al., 2025), de façon similaire à ce qui a été décrit après infection. Il est toutefois difficile de distinguer la Spike vaccinale (mutations 2P) de la Spike virale avec les tests actuels. - Difficulté à exclure une infection antérieure : les anticorps anti-nucléocapside sont moins souvent détectés chez les vaccinés infectés et diminuent avec le temps, ce qui complique l’interprétation. 🔴 Conclusion L’historique clinique détaillé (et le statut infectieux documenté) reste la base. Les marqueurs de recherche (auto-anticorps, anticorps GPCR + IL-6, protéomique des caillots, peptides de Spike) peuvent être combinés, mais **aucun test unique n’est prêt pour un usage clinique**. Résumé produit par Grok. 🧵⤵️
1/ Long COVID and post-acute COVID-19 vaccination syndrome (PACVS) share the same core picture: fatigue, brain fog, post-exertional malaise, dysautonomia. No routine clinical test separates them. What does the biomarker research show? 🧵 Fig: Purpura et al., Clin Infect Dis 2026 (CC BY-NC-ND 4.0)
2
2
1
5
404
Replying to @MatthewHalma
Many of us have severe immune dysfunctions well. What is interesting is the longer time passes, we are looking more similar in my opinion. Issues we didn’t begin with, we somehow acquire. I didn’t start with cardiac issues for example, but after 2 years I had them along with MCAS/pots etc. It seems we are converging in a sense. 5 years out, now I’m having emboli. It’s both scary and interesting.
It’s been 1,967 days since my life flipped. It’s been 1 day since I left the hospital, for the 4th time this year after my body tried its best to take me out! I was diagnosed with 4 embolisms in addition to sepsis after a weeks long stay at my version of the local Hilton Hotel. They don’t seem to offer frequent stay points thought. “Septic thrombophlebitis” is the technical term for what I’m dealing with and let me tell you, it is not a joy to live with. I’ll be on 24 hour antibiotics for 4 weeks in addition to medication to thin my blood coupled with a prayer or two for improvement. It’s a never ending battle and I’ve gotten used to my body trying to take me out sadly! That said I’m not sure if I’ve ever shared my story as a whole so I thought I would now. I missed vaccine injury month but better late than never I suppose. A huge thank you to the warriors out there fighting the good fight for us. You are appreciated more than there are words to offer. Thank you. For those interested, my story follows below. I was a Registered Nurse for 20 years, seventeen of them in hospice and palliative care. Until 2019 I was a single mother raising my six-year-old son alone. That year I met my future husband, a doctor of occupational therapy, and his daughter. We married in the fall of 2020, blending our families and planning a bright future. Both of us in healthcare, we filled weekends with primitive camping, hiking, fishing, and snow tubing, and evenings with soccer practice, team treats, and a walk on the bike trail after dinner. We were already looking at a second property on a lake so the adventures could become permanent. I had reached a place of good health, financial stability, and love. On June 4, 2021, I received the first of two Pfizer doses. About eighteen days later I developed sudden severe back pain and was sent home from the ER with a “pulled muscle.” I took the second dose on June 26. Within hours I fell for no clear reason. The next day the injected arm was excruciating, pain radiating into my face, with numbness, tingling, and decreased mobility. Again the ER had no answers. Around day eighteen the back pain returned and, over four days, I lost the ability to walk, developed swallowing problems, lost bowel and bladder control, and began having severe muscle spasms. An outpatient MRI showed demyelination from C3 to C7. After a five-day hospital stay my team concluded the vaccine had caused my body to attack my spinal cord—transverse myelitis. The damage was already done; only outpatient therapy offered hope. Within months I was permanently disabled. SSDI came at the end of 2021 at a fraction of my former salary. Medicare was two years away, so I stayed on a high-deductible plan. Medical debt mounted. Braces, scooters, beds, bathroom equipment, handrails, and caregivers were all out of pocket. Savings, my 401k, and credit cards were gone the first year. @React19org care fund helped offset some cost as well as secure treatment making it possible to avoid the choice between food and care. Without clear guidance on vaccine injury, I continued to decline through 2022–2024. Multiple hospitalizations brought progressive loss of respiratory function, cardiovascular collapse, heart failure, and life-threatening immune collapse. Small early gains from therapy vanished. Outside specialists rejected referrals because of the vaccine-injury label, and insurance denied specialized testing while covering almost none of the practical support I needed at home. By late 2024 my team said hospice or palliative care was the only remaining option. Exhausted, I began writing letters for my son—then eleven—for the occasions I would miss. He already carried the fear that I might not wake up. React19’s cofounder Brianne Dressen connected me with a provider familiar with vaccine injuries; I was diagnosed with CIDP. In 2025 I started in-home IVIG every three weeks. (Continued)
1
3
124
GPCR? At least folks don't have to use Peptide T. Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC) pmc.ncbi.nlm.nih.gov/article…
Long COVID and post-vaccine syndrome (PACVS) look nearly identical: fatigue, brain fog, PEM, dysautonomia. There’s still no single routine test that cleanly separates them. What are the leading biomarker candidates? Classical autoantibodies, GPCR autoantibodies + IL-6, microclot proteomics, and persistent spike protein. What are the gaps and what can existing science tell us? #LongCOVID #PACVS #Biomarkers youtu.be/4z_tcdLm8zg
2
5
369
Matthew Halma retweeted
Replying to @MatthewHalma
Thank you for summarising the current state of the diagnostics for Long Covid & PACVS. There’s a vital need for more research and open discussion around diagnosis & treatments. Even 3 years ago the literature was showing overlap of these two conditions, as our and Scholkmann & May’s literature reviews found: pubmed.ncbi.nlm.nih.gov/3762… pubmed.ncbi.nlm.nih.gov/3719…
1
2
2
185
Matthew Halma retweeted
🧐
1/ Long COVID and post-acute COVID-19 vaccination syndrome (PACVS) share the same core picture: fatigue, brain fog, post-exertional malaise, dysautonomia. No routine clinical test separates them. What does the biomarker research show? 🧵 Fig: Purpura et al., Clin Infect Dis 2026 (CC BY-NC-ND 4.0)
2
2
147
Matthew Halma retweeted
Thread🧵
1/ A new paper may be the first real step toward separating PACVS from Long COVID, which has been a tricky problem with implications for understanding disease biology, for afforiding compensation, and for monitoring vaccine adverse events. Purpura et al. 2026 (Clin Infect Dis, doi:10.1093/cid/ciaf624): 181 patients, clinically PACVS/ME-CFS/Long COVID look nearly identical, but PACVS shows a distinct autoantibody signature. anticardiolipin IgM 42.9% vs 11.6% in Long COVID (p=.02) anti-U1-RNP 21.4% vs 2.3% (p=.04). This work may help to differentiate Long COVID from PACVS.
1
1
135
A major academic center, NIH-funded, publishing in the IDSA's flagship journal, has documented a post-vaccination syndrome that is clinically indistinguishable in severity from ME/CFS long COVID, temporally locked to the injection, occurring in people who never had the virus, and carrying a distinct autoantibody signature. The framing is cautious. The data are not. The people who were called liars for describing this in 2021 were describing it accurately. The literature is just catching up slowly enough to save face.
1/ A new paper may be the first real step toward separating PACVS from Long COVID, which has been a tricky problem with implications for understanding disease biology, for afforiding compensation, and for monitoring vaccine adverse events. Purpura et al. 2026 (Clin Infect Dis, doi:10.1093/cid/ciaf624): 181 patients, clinically PACVS/ME-CFS/Long COVID look nearly identical, but PACVS shows a distinct autoantibody signature. anticardiolipin IgM 42.9% vs 11.6% in Long COVID (p=.02) anti-U1-RNP 21.4% vs 2.3% (p=.04). This work may help to differentiate Long COVID from PACVS.
5
70
3
154
5,085
Matthew Halma retweeted
CDC researchers argue that Long COVID, ME/CFS, POTS, and other chronic illnesses following infections deserve a unified public health response. Long COVID offers a chance to change that. academic.oup.com/ofid/articl…
3
44
2
179
3,642
Matthew Halma retweeted
It is hard to overestimate how big an earthquake yesterday was - look at the shift among young voters. Either Republicans stand up to Trump and make him change in both style and policy (or disavow him if he won't), or they have NO chance in 2028. Those are the only choices.
The old man was treated unfairly in 2016, when they tried to crown Hillary 2018, when they pretended he was a Russian spy 2020, when they pretended Covid was the plague 2024, when they prosecuted him for the crime of beating Hillary But there’s nothing unfair about the ass-whipping he is about to take. He deserves every inch of it and more. This time around he has become the grifting incompetent doddering fool they said he was, he has leaned in to the caricature so far he’s fallen over and taken the Republican Party with him. I take no joy in writing this, I voted for him in 2024 and hoped for better. But the next two years will be brutal, and he has only himself and the thieving courtiers he installed around him to blame. Happy Election Day, El Hombre Naranja
91
49
5
470
37,653
Fatigue resolved in 91% of subjects by day 14 while taking a systemic/proteolytic enzyme supplement along with a pro/synbiotic(ImmunoSEB + ProbioSEB CSC3). ...Once again, the synbiotic approach is giving the strongest signal in the Long Covid treatment lit(among SIM01 and VSL#3). pubmed.ncbi.nlm.nih.gov/3456…
10
47
4
294
13,319
Matthew Halma retweeted
This Tuesday we meet Dr Joshua Guetzkow (@joshg99), Senior Lecturer in Sociology & Anthropology and the Institute of Criminology at the Hebrew University of Jerusalem. We discuss his 2025 preprint on observed-to-expected fetal losses after mRNA COVID-19 vaccination in early pregnancy, which analyzes 226,395 pregnancies in Israel. 📄 Guetzkow J, Patalon T, Gazit S, Hegg TB, Fraiman J, Segal Y, et al. medRxiv 2025. doi:10.1101/2025.06.18.25352952 🗓 Tue 3 Nov · 9–10 AM PT · 10–11 AM MT · 12–1 PM ET · 6–7 PM CET Hosted by Matthew Halma · opensourcemed.info · #PACVS teapawt.net/i/broadcasts/2AMXdqWdv…
2
2
2
477
Matthew Halma retweeted
This Tuesday we meet Dr Joshua Guetzkow (@joshg99), Senior Lecturer in Sociology & Anthropology and the Institute of Criminology at the Hebrew University of Jerusalem. We discuss his 2025 preprint on observed-to-expected fetal losses after mRNA COVID-19 vaccination in early pregnancy, which analyzes 226,395 pregnancies in Israel. 📄 Guetzkow J, Patalon T, Gazit S, Hegg TB, Fraiman J, Segal Y, et al. medRxiv 2025. doi:10.1101/2025.06.18.25352952 🗓 Tue 3 Nov · 9–10 AM PT · 10–11 AM MT · 12–1 PM ET · 6–7 PM CET Hosted by Matthew Halma · opensourcemed.info · #PACVS teapawt.net/i/broadcasts/2AMXdqWdv…
1
110
Matthew Halma retweeted
Join us for a live conversation with Michelle Worton & Julie Woods, co-founders of @CANrise19Org. Building support for vaccine-injured Canadians. Topics include: • Gaps in Canada’s vaccine injury program • Long COVID clinics/research vs. vaccine-injury support • What patients and researchers need next Tuesday, Oct 27 10–11 AM MT / 12–1 PM ETLivestream on X: teapawt.net/i/broadcasts/1RKZzBMVW… #VaccineInjury #LongCOVID #CANrise19 teapawt.net/i/broadcasts/1RKZzBMVW…
6
1
6
377
📝 – at Niigata City Chuo Ward, Niigata
Replying to @MatthewHalma
Why would creatine help long COVID? Long COVID disrupts mitochondrial energy production. Creatine, as phosphocreatine, is an immediate energy reserve — it rapidly regenerates ATP during periods of high energy demand. In a system where mitochondrial ATP production is already impaired, phosphocreatine buffering becomes critically important.
1
81